Menu
Recruiting NCT03326154

Post-Cholecystectomy Quality of Life

Observational Gallstone

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention, observational.
Who it may be relevant to
Registry conditions: Gallstone. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Health Related Quality of Life and Abdominal Symptoms After Cholecystectomy

Overview

The study aims to identify factors associated with no increase in gastrointestinal quality of life after elective cholecystectomy for gallstones.

Interventions

  • Other No intervention, observational
    Observation

Primary outcome measures

  • Quality of life: Gastrointestinal Quality of Life GIQLI score [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • laparoscopic cholecystectomy patients
  • indication for operation symptomatic gallstones

Exclusion criteria

  • previous complication of gallstone disease
  • indication for cholecystectomy other than symptomatic gallstones
  • illness significantly lowering quality of life
  • inability to fill in questionnaires
  • denies participation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Finland · 2 centers
  • Jorvi, Helsinki University Hospital — Espoo
  • HUS Hyvinkää Hospital — Hyvinkää

Identifiers

NCT: NCT03326154 · HUS/2317/2016

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗